SCHEMBL2584512

SCHEMBL2584512

CCOC(=O)[C@H]1CCC(c2cccc(F)c2)=N1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 5/20 0.46
ALDH1A1 P00352 4/20 0.45
HPGD P15428 2/20 0.45
HSD17B10 Q99714 2/20 0.45
TSHR P16473 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
LMNA P02545 3/20 0.42
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
JAK2 O60674 1/20 0.40
JAK3 P52333 1/20 0.40
ATM Q13315 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
KDM4E B2RXH2 1/20 0.38
HTT P42858 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CSNK1D P48730 1/20 0.38
F2R P25116 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2585920 0.87 XPO1 (0.39) TRPM8ALDH1A1HPGDHSD17B10TSHR
SCHEMBL5516318 0.86 CA1 (0.42) TRPM8RAB9ANPC1ATMCHRNB4
SCHEMBL31479166 0.86 CA1 (0.42) TRPM8RAB9ANPC1ATMCHRNB4
SCHEMBL2586557 0.85 TRPM8 (0.46) TRPM8ALDH1A1HSD17B10LMNAJAK2
SCHEMBL22040222 0.85 NR3C2 (0.43) TRPM8ALDH1A1HPGDHSD17B10TSHR
SCHEMBL20835448 0.84 RAB9A (0.51) ALDH1A1HPGDHSD17B10TSHRNPSR1
SCHEMBL7169265 0.84 RAB9A (0.51) ALDH1A1HPGDHSD17B10TSHRNPSR1
SCHEMBL2344446 0.84 ALDH1A1 (0.46) ALDH1A1TSHRLMNATDP1KDM4E
SCHEMBL2344442 0.84 ALDH1A1 (0.46) ALDH1A1TSHRLMNATDP1KDM4E
SCHEMBL28674985 0.83 HSD17B10 (0.36) ALDH1A1HSD17B10RAB9AATMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10995084-B2 Pyrrolidine derivative KISSEI PHARMACEUTICAL CO., LTD. (JP) 2021-05-04 US disclosed
CN-109476639-B Pyrrolidine derivatives 橘生药品工业股份有限公司 2021-02-26 CN disclosed
US-20200299273-A1 PYRROLIDINE DERIVATIVE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2020-09-24 US disclosed
EP-3459941-A1 PYRROLIDINE DERIVATIVE Kissei Pharmaceutical Co., Ltd. (JP) 2019-03-27 EP disclosed
US-8048878-B2 Two cyclic cinnamide compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200299273-A1 PYRROLIDINE DERIVATIVE CALCRL, NPY1R, GRPR TRPM8 266/4885ALDH1A1 2551/4885HPGD 818/4885
US-10995084-B2 Pyrrolidine derivative CALCRL, NPY1R, GRPR TRPM8 266/4885ALDH1A1 2551/4885HPGD 818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.